You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
*ST藍豐(002513.SZ)向中鈺雕龍出售陝西方舟製藥有限公司100%股權完成工商變更登記
格隆匯 12-28 18:20

格隆匯 12 月 28日丨*ST藍豐(002513.SZ)公佈,公司於2020年12月3日召開了第五屆董事會第九次會議,會議審議通過了《關於公司向北京中鈺雕龍醫療信息技術有限公司轉讓全資子公司陝西方舟製藥有限公司100%股權的議案》,公司在2020年11月30日與北京中鈺雕龍醫療信息技術有限公司(“中鈺雕龍”)簽訂了《股權轉讓協議》,公司將以4.5億元股權轉讓總價向中鈺雕龍轉讓全資子公司陝西方舟製藥有限公司100股權。公司已於12月7日和12月8日收到中鈺雕龍按股權轉讓協議支付的第一階段股權轉讓款1億元。

2020年12月25日,陝西方舟製藥有限公司已就相關事項完成工商變更登記,並取得了陝西省銅川市行政審批服務局核發的《營業執照》(統一社會信用代碼:91610200221270442P)。此次股權轉讓完成後,公司不再持有陝西方舟製藥有限公司股權,不再將其納入公司合併財務報表範圍。陝西方舟製藥有限公司控股股東為北京中鈺雕龍醫療信息技術有限公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account